Titan’s Probuphine gains more media attention

The Herald Bulletin of Madison County, Indiana has published a feature about Titan Pharmaceuticals’ (NASDAQ:TTNP) Probuphine implant for the treatment of opioid addiction.

The article highlights Probuphine's ability to provide around-the-clock, stable levels of buprenorphine for six months, significantly benefiting patients and clinicians by assisting with compliance and by decreasing the possibility of abuse or diversion.